Delivery Order 75N95022D00013-75N95025F00001

Award Date 5/21/25
Potential Completion Date 5/20/28
Potential Value $546K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded to CCS Associates, Inc., a woman-owned small business, by the Food and Drug Administration (FDA) for a quality assurance and quality improvement program to review clinical trials supported or funded by the FDA. The contract has a ceiling value of $87,620.95 and a period of performance that ends on March 29, 2019. It is a time and materials contract type. CCS Associates has received numerous federal contracts and grants, including several large indefinite...
This federal contract award, valued at $2,471,797.88, was issued by the National Heart Lung and Blood Institute (NHLBI) to CCS Associates, Inc., a woman-owned small business. The contract is for research and development related to vascular intervention and therapeutic advances. It is a Cost Plus Fixed Fee contract with a total small business set-aside. CCS Associates has extensive experience supporting federal agencies like the Department of Health and Human Services, National Institutes of...
This is a $14,191,273.43 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to CCS Associates, Inc., a woman-owned small business. The contract is for technical information research resources to support cancer preventive agent development. CCS Associates has extensive expertise supporting pharmaceutical research, clinical trials, regulatory submissions, and consulting for federal agencies like NIH. The contract has...
This $548,714.60 firm fixed-price delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to CCS Associates, Inc., a woman-owned small business. The contract is for TAS (Task Area Support) to provide strategic planning and activities support for NCI's Center for Strategic Scientific Initiatives (CSSI). CCS Associates specializes in providing comprehensive research support services to federal agencies,...
This is a delivery order contract awarded to CCS Associates, Inc., a woman-owned small business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The $3,882,241.70 firm fixed price contract provides administrative support services to the NCI. CCS Associates has secured numerous federal contracts and grants to assist government agencies in advancing medical research and drug development...
CCS Associates, Inc. was awarded a delivery order against an unspecified contract vehicle to provide regulatory support services to the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health (NIH). The $115,581.31 contract calls for CCS Associates to prepare and file a Pre-Investigational New Drug (Pre-IND) application with the Food and Drug Administration (FDA) to support the clinical development of mitragynine. No set-aside designation was...
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to CCS Associates, Inc., a woman-owned small business. The $145,992 Firm Fixed Price contract was awarded under the Small Business Innovation Research (SBIR) Program Phase I for biomedical research. The contract has a completion date of May 15, 2010. CCS Associates specializes in providing research...
This is a firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to CCS Associates, Inc., a woman-owned small business. The $776,157.30 contract supports cancer prevention efforts through information management, regulatory services, and technical support. CCS Associates has secured numerous federal contract and grant awards from NIH institutes and centers,...
This is a Cost Plus Fixed Fee delivery order contract valued at $131,513.00, awarded by the National Institute on Drug Abuse (NIDA) to CCS Associates, Inc., a woman-owned small business. The contract is for regulatory preparation, review, and submission services related to clinical trials associated with NIDA's Drug Supply Program. The period of performance is from April 1, 2025 to March 31, 2026. CCS Associates is an experienced federal contractor, holding several significant indefinite...
This federal contract award, valued at $1,639,274.31, was granted to CCS Associates, Inc., a woman-owned small business, by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the provision of systematic literature reviews, assessments, and meta-analyses. CCS Associates has secured numerous federal contracts and grants to support medical research and drug development initiatives...
  • 75N95022D00013
    Indefinite Delivery Contract
  • 75N95022D00013-75N95025F00001
    Delivery Order

This is a delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to CCS Associates, Inc., a woman-owned small business based in San Jose, California. The $545,690.33 contract is for regulatory activities supporting the development of gene therapy products for PCCA and MMAB. The contract is not set aside and has a completion date of May 20, 2028. CCS Associates, Inc. has been awarded multiple federal contracts and grants, including a $19.4 million Indefinite Delivery Vehicle contract with the National Center for Advancing Translational Sciences and a $1.1 million grant from the Food and Drug Administration's Center for Drug Evaluation and Research to advance a pharmacodynamic biomarker for oncologic drug clinical trials.

Generated 5/22/25, 8:21 PM